ELLINGTON MANAGEMENT GROUP LLC - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 145 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.9%.

Quarter-by-quarter ownership
ELLINGTON MANAGEMENT GROUP LLC ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$471,000
+59.1%
55,000
+128.2%
0.03%
-33.3%
Q3 2017$296,000
+76.2%
24,100
+106.0%
0.05%
-78.2%
Q2 2016$168,000
-48.5%
11,700
-57.1%
0.23%
+67.1%
Q1 2016$326,000
+169.4%
27,300
+82.0%
0.14%
+366.7%
Q2 2015$121,00015,0000.03%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Ulys, L.L.C. 4,321,214$34,786,00099.98%
Artal Group S.A. 57,517,978$463,019,00019.93%
MASTERS CAPITAL MANAGEMENT LLC 1,129,708$9,094,0000.30%
Rhenman & Partners Asset Management AB 170,915$1,376,0000.16%
Round Table Services, LLC 21,611$174,0000.14%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 35,714$287,0000.10%
FALCON POINT CAPITAL, LLC 37,039$298,0000.10%
SABBY MANAGEMENT, LLC 318,775$2,566,0000.09%
WILLIAM HARRIS INVESTORS INC 39,495$318,0000.09%
HOWARD HUGHES MEDICAL INSTITUTE 51,520$415,0000.09%
View complete list of LEXICON PHARMACEUTICALS INC shareholders